Ignite Creation Date:
2024-05-05 @ 10:25 PM
Last Modification Date:
2024-10-26 @ 10:18 AM
Study NCT ID:
NCT01103635
Status:
COMPLETED
Last Update Posted:
2020-04-07
First Post:
2010-04-12
Brief Title:
Tremelimumab and CP-870893 in Patients With Metastatic Melanoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Melanoma |
| Recurrent Melanoma |
Keywords: